Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Shared patient and provider values in end-stage renal disease decision making: Identifying the tensions.

Vandenberg AE, Bowling CB, Adisa O, Sahlie A, Nadel L, Lea J, Plantinga LC.

Patient Educ Couns. 2019 Feb 11. pii: S0738-3991(19)30037-0. doi: 10.1016/j.pec.2019.02.012. [Epub ahead of print]

PMID:
30803904
2.

Association of social worker-assessed psychosocial factors with 30-day hospital readmissions among hemodialysis patients.

Adisa O, Jaar BG, Masud T, Sahlie A, Obadina C, Ang J, Lea JP, Plantinga LC.

BMC Nephrol. 2018 Dec 17;19(1):360. doi: 10.1186/s12882-018-1162-4.

3.

Recent History of Serious Fall Injuries and Posttransplant Outcomes among U.S. Kidney Transplant Recipients.

Lynch RJ, Patzer RE, Pastan SO, Bowling CB, Plantinga LC.

Transplantation. 2018 Sep 21. doi: 10.1097/TP.0000000000002463. [Epub ahead of print]

PMID:
30247319
4.

Post-hospitalization dialysis facility processes of care and hospital readmissions among hemodialysis patients: a retrospective cohort study.

Plantinga LC, Masud T, Lea JP, Burkart JM, O'Donnell CM, Jaar BG.

BMC Nephrol. 2018 Jul 31;19(1):186. doi: 10.1186/s12882-018-0983-5.

5.

Racial/ethnic disparities in waitlisting for deceased donor kidney transplantation 1 year after implementation of the new national kidney allocation system.

Zhang X, Melanson TA, Plantinga LC, Basu M, Pastan SO, Mohan S, Howard DH, Hockenberry JM, Garber MD, Patzer RE.

Am J Transplant. 2018 Aug;18(8):1936-1946. doi: 10.1111/ajt.14748. Epub 2018 Apr 18.

PMID:
29603644
6.

Association of Serious Fall Injuries among United States End Stage Kidney Disease Patients with Access to Kidney Transplantation.

Plantinga LC, Lynch RJ, Patzer RE, Pastan SO, Bowling CB.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):628-637. doi: 10.2215/CJN.10330917. Epub 2018 Mar 6.

PMID:
29511059
7.

Standardized Transplantation Referral Ratio to Assess Performance of Transplant Referral among Dialysis Facilities.

Paul S, Plantinga LC, Pastan SO, Gander JC, Mohan S, Patzer RE.

Clin J Am Soc Nephrol. 2018 Feb 7;13(2):282-289. doi: 10.2215/CJN.04690417. Epub 2018 Jan 25.

8.

Serious Fall Injury History and Adverse Health Outcomes After Initiating Hemodialysis Among Older U.S. Adults.

Bowling CB, Hall RK, Khakharia A, Franch HA, Plantinga LC.

J Gerontol A Biol Sci Med Sci. 2018 Aug 10;73(9):1216-1221. doi: 10.1093/gerona/glx260.

PMID:
29346522
9.

Burden and correlates of readmissions related to pulmonary edema in US hemodialysis patients: a cohort study.

Plantinga LC, King LM, Masud T, Shafi T, Burkart JM, Lea JP, Jaar BG.

Nephrol Dial Transplant. 2018 Jul 1;33(7):1215-1223. doi: 10.1093/ndt/gfx335.

PMID:
29294094
10.

SPIRIT trial: A phase III pragmatic trial of an advance care planning intervention in ESRD.

Song MK, Unruh ML, Manatunga A, Plantinga LC, Lea J, Jhamb M, Kshirsagar AV, Ward SE.

Contemp Clin Trials. 2018 Jan;64:188-194. doi: 10.1016/j.cct.2017.10.005. Epub 2017 Oct 6.

11.

On the Right Track: Implementing Interventions to Reduce Readmissions in Dialysis Patients.

Plantinga LC, Jaar BG.

Am J Nephrol. 2017;45(6):549-551. doi: 10.1159/000477100. Epub 2017 May 25. No abstract available.

12.

Early hospital readmission among hemodialysis patients in the United States is associated with subsequent mortality.

Plantinga LC, King L, Patzer RE, Lea JP, Burkart JM, Hockenberry JM, Jaar BG.

Kidney Int. 2017 Oct;92(4):934-941. doi: 10.1016/j.kint.2017.03.025. Epub 2017 May 20.

PMID:
28532710
13.

When All You Have Is a Hammer: The Need for Tools to Define and Apply Patient-Centered Outcomes in Hemodialysis.

Bowling CB, Plantinga LC.

Clin J Am Soc Nephrol. 2017 Mar 7;12(3):382-384. doi: 10.2215/CJN.00550117. Epub 2017 Feb 21. No abstract available.

14.

Serious Fall Injuries Before and After Initiation of Hemodialysis Among Older ESRD Patients in the United States: A Retrospective Cohort Study.

Plantinga LC, Patzer RE, Franch HA, Bowling CB.

Am J Kidney Dis. 2017 Jul;70(1):76-83. doi: 10.1053/j.ajkd.2016.11.021. Epub 2017 Jan 27.

PMID:
28139394
15.

Referral for Kidney Transplantation and Indicators of Quality of Dialysis Care: A Cross-sectional Study.

Plantinga LC, Pastan SO, Wilk AS, Krisher J, Mulloy L, Gibney EM, Patzer RE.

Am J Kidney Dis. 2017 Feb;69(2):257-265. doi: 10.1053/j.ajkd.2016.08.038. Epub 2016 Nov 20.

16.

ESRD Databases, Public Policy, and Quality of Care: Translational Medicine and Nephrology.

McClellan WM, Plantinga LC, Wilk AS, Patzer RE.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):210-216. doi: 10.2215/CJN.02370316. Epub 2016 Nov 16. Review.

17.

Comparison of vascular access outcomes in patients with end-stage renal disease attributed to systemic lupus erythematosus vs. other causes: a retrospective cohort study.

Plantinga LC, Lim SS, Patzer RE, Pastan SO, Drenkard C.

BMC Nephrol. 2016 Jul 7;17(1):64. doi: 10.1186/s12882-016-0274-y.

18.

Attribution of cause of end-stage renal disease among patients with systemic lupus erythematosus: the Georgia Lupus Registry.

Plantinga LC, Drenkard C, Pastan SO, Lim SS.

Lupus Sci Med. 2016 Jan 22;3(1):e000132. doi: 10.1136/lupus-2015-000132. eCollection 2016.

19.

Variation in Dialysis Facility Referral for Kidney Transplantation Among Patients With End-Stage Renal Disease in Georgia.

Patzer RE, Plantinga LC, Paul S, Gander J, Krisher J, Sauls L, Gibney EM, Mulloy L, Pastan SO.

JAMA. 2015 Aug 11;314(6):582-94. doi: 10.1001/jama.2015.8897.

20.

Comparison of quality-of-care measures in U.S. patients with end-stage renal disease secondary to lupus nephritis vs. other causes.

Plantinga LC, Patzer RE, Drenkard C, Pastan SO, Cobb J, McClellan W, Lim SS.

BMC Nephrol. 2015 Mar 29;16:39. doi: 10.1186/s12882-015-0037-1.

21.

Sociodemographic and geographic predictors of quality of care in United States patients with end-stage renal disease due to lupus nephritis.

Plantinga LC, Drenkard C, Patzer RE, Klein M, Kramer MR, Pastan S, Lim SS, McClellan WM.

Arthritis Rheumatol. 2015 Mar;67(3):761-72. doi: 10.1002/art.38983.

22.

Association of time to kidney transplantation with graft failure among U.S. patients with end-stage renal disease due to lupus nephritis.

Plantinga LC, Patzer RE, Drenkard C, Kramer MR, Klein M, Lim SS, McClellan WM, Pastan SO.

Arthritis Care Res (Hoboken). 2015 Apr;67(4):571-81. doi: 10.1002/acr.22482.

23.

Biomarkers of vascular calcification and mortality in patients with ESRD.

Scialla JJ, Kao WH, Crainiceanu C, Sozio SM, Oberai PC, Shafi T, Coresh J, Powe NR, Plantinga LC, Jaar BG, Parekh RS.

Clin J Am Soc Nephrol. 2014 Apr;9(4):745-55. doi: 10.2215/CJN.05450513. Epub 2014 Jan 23.

24.

Pre-end-stage renal disease care not associated with dialysis facility neighborhood poverty in the United States.

Plantinga LC, Kim M, Goetz M, Kleinbaum DG, McClellan W, Patzer RE.

Am J Nephrol. 2014;39(1):50-8. doi: 10.1159/000358067. Epub 2014 Jan 15.

25.

A public health perspective on CKD and obesity.

McClellan WM, Plantinga LC.

Nephrol Dial Transplant. 2013 Nov;28 Suppl 4:iv37-42. doi: 10.1093/ndt/gft030. Review.

PMID:
24179014
26.

Estimating prevalence of CKD stages 3-5 using health system data.

Shahinian VB, Hedgeman E, Gillespie BW, Young EW, Robinson B, Hsu CY, Plantinga LC, Burrows NR, Eggers P, Saydah S, Powe NR, Saran R; CDC CKD Surveillance System.

Am J Kidney Dis. 2013 Jun;61(6):930-8. doi: 10.1053/j.ajkd.2013.01.018. Epub 2013 Mar 13.

27.

Americans' use of dietary supplements that are potentially harmful in CKD.

Grubbs V, Plantinga LC, Tuot DS, Hedgeman E, Saran R, Saydah S, Rolka D, Powe NR; Centers for Disease Control and Prevention CKD Surveillance Team.

Am J Kidney Dis. 2013 May;61(5):739-47. doi: 10.1053/j.ajkd.2012.12.018. Epub 2013 Feb 14.

28.

Healthy behaviors, risk factor control and awareness of chronic kidney disease.

Tuot DS, Plantinga LC, Judd SE, Muntner P, Hsu CY, Warnock DG, Gutiérrez OM, Safford M, Powe NR, McClellan WM; REGARDS Investigators.

Am J Nephrol. 2013;37(2):135-43. doi: 10.1159/000346712. Epub 2013 Jan 31.

29.

Socio-economic impact in CKD.

Plantinga LC.

Nephrol Ther. 2013 Feb;9(1):1-7. doi: 10.1016/j.nephro.2012.07.361. Epub 2013 Jan 12. Review.

PMID:
23318113
30.

Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients.

Shafi T, Sozio SM, Plantinga LC, Jaar BG, Kim ET, Parekh RS, Steffes MW, Powe NR, Coresh J, Selvin E.

Diabetes Care. 2013 Jun;36(6):1522-33. doi: 10.2337/dc12-1896. Epub 2012 Dec 18.

31.

Medicare immunosuppressant coverage and access to kidney transplantation: a retrospective national cohort study.

Grubbs V, Plantinga LC, Vittinghoff E, O'Hare AM, Dudley RA.

BMC Health Serv Res. 2012 Aug 16;12:254. doi: 10.1186/1472-6963-12-254.

32.

Serum β-trace protein and risk of mortality in incident hemodialysis patients.

Shafi T, Parekh RS, Jaar BG, Plantinga LC, Oberai PC, Eckfeldt JH, Levey AS, Powe NR, Coresh J.

Clin J Am Soc Nephrol. 2012 Sep;7(9):1435-45. doi: 10.2215/CJN.02240312. Epub 2012 Jun 28.

33.

Chronic kidney disease identification in a high-risk urban population: does automated eGFR reporting make a difference?

Plantinga LC, Tuot DS, Grubbs V, Hsu CY, Powe NR.

J Urban Health. 2012 Dec;89(6):965-76. doi: 10.1007/s11524-012-9726-2.

34.

Chronic kidney disease and use of dental services in a United States public healthcare system: a retrospective cohort study.

Grubbs V, Plantinga LC, Tuot DS, Powe NR.

BMC Nephrol. 2012 Apr 2;13:16. doi: 10.1186/1471-2369-13-16.

35.

Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes?

Tuot DS, Plantinga LC, Hsu CY, Powe NR.

Am J Nephrol. 2012;35(2):191-7. doi: 10.1159/000335935. Epub 2012 Jan 27.

36.

Lower socioeconomic status and disability among US adults with chronic kidney disease, 1999-2008.

Plantinga LC, Johansen KL, Schillinger D, Powe NR.

Prev Chronic Dis. 2012;9:E12. Epub 2011 Dec 15.

37.

What patients don't know may hurt them: knowledge and the perception of knowledge among patients with CKD.

Tuot DS, Plantinga LC.

Kidney Int. 2011 Dec;80(12):1256-7. doi: 10.1038/ki.2011.269.

38.

Chronic kidney disease awareness among individuals with clinical markers of kidney dysfunction.

Tuot DS, Plantinga LC, Hsu CY, Jordan R, Burrows NR, Hedgeman E, Yee J, Saran R, Powe NR; Centers for Disease Control Chronic Kidney Disease Surveillance Team.

Clin J Am Soc Nephrol. 2011 Aug;6(8):1838-44. doi: 10.2215/CJN.00730111. Epub 2011 Jul 22.

39.

Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis.

Sozio SM, Coresh J, Jaar BG, Fink NE, Plantinga LC, Armstrong PA, Longenecker JC, Sharrett AR, Powe NR, Parekh RS.

Clin J Am Soc Nephrol. 2011 Jun;6(6):1292-300. doi: 10.2215/CJN.08350910. Epub 2011 May 5.

40.

Vulnerable populations and the association between periodontal and chronic kidney disease.

Grubbs V, Plantinga LC, Crews DC, Bibbins-Domingo K, Saran R, Heung M, Patel PR, Burrows NR, Ernst KL, Powe NR; Centers for Disease Control and Prevention CKD Surveillance Team.

Clin J Am Soc Nephrol. 2011 Apr;6(4):711-7. doi: 10.2215/CJN.08270910. Epub 2011 Feb 24.

41.

Soluble P-selectin levels are associated with cardiovascular mortality and sudden cardiac death in male dialysis patients.

Scialla JJ, Plantinga LC, Kao WH, Jaar B, Powe NR, Parekh RS.

Am J Nephrol. 2011;33(3):224-30. doi: 10.1159/000324517. Epub 2011 Feb 23.

42.

Association of CKD with disability in the United States.

Plantinga LC, Johansen K, Crews DC, Shahinian VB, Robinson BM, Saran R, Burrows NR, Williams DE, Powe NR; CDC CKD Surveillance Team.

Am J Kidney Dis. 2011 Feb;57(2):212-27. doi: 10.1053/j.ajkd.2010.08.016. Epub 2010 Oct 30.

43.

Validation of CKD and related conditions in existing data sets: A systematic review.

Grams ME, Plantinga LC, Hedgeman E, Saran R, Myers GL, Williams DE, Powe NR; CDC CKD Surveillance Team.

Am J Kidney Dis. 2011 Jan;57(1):44-54. doi: 10.1053/j.ajkd.2010.05.013. Epub 2010 Aug 6. Review.

44.

Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.

Shafi T, Jaar BG, Plantinga LC, Fink NE, Sadler JH, Parekh RS, Powe NR, Coresh J.

Am J Kidney Dis. 2010 Aug;56(2):348-58. doi: 10.1053/j.ajkd.2010.03.020. Epub 2010 Jun 3.

45.

Awareness of chronic kidney disease among patients and providers.

Plantinga LC, Tuot DS, Powe NR.

Adv Chronic Kidney Dis. 2010 May;17(3):225-36. doi: 10.1053/j.ackd.2010.03.002.

46.

Association of social support with outcomes in incident dialysis patients.

Plantinga LC, Fink NE, Harrington-Levey R, Finkelstein FO, Hebah N, Powe NR, Jaar BG.

Clin J Am Soc Nephrol. 2010 Aug;5(8):1480-8. doi: 10.2215/CJN.01240210. Epub 2010 Apr 29.

47.

Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes.

Plantinga LC, Crews DC, Coresh J, Miller ER 3rd, Saran R, Yee J, Hedgeman E, Pavkov M, Eberhardt MS, Williams DE, Powe NR; CDC CKD Surveillance Team.

Clin J Am Soc Nephrol. 2010 Apr;5(4):673-82. doi: 10.2215/CJN.07891109. Epub 2010 Mar 25.

48.

Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States.

Crews DC, Plantinga LC, Miller ER 3rd, Saran R, Hedgeman E, Saydah SH, Williams DE, Powe NR; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team.

Hypertension. 2010 May;55(5):1102-9. doi: 10.1161/HYPERTENSIONAHA.110.150722. Epub 2010 Mar 22.

49.

Preventing repeat hospitalizations in dialysis patients: a call for action.

Plantinga LC, Jaar BG.

Kidney Int. 2009 Aug;76(3):249-51. doi: 10.1038/ki.2009.145.

50.

Inpatient hemodialysis initiation: reasons, risk factors and outcomes.

Crews DC, Jaar BG, Plantinga LC, Kassem HS, Fink NE, Powe NR.

Nephron Clin Pract. 2010;114(1):c19-28. doi: 10.1159/000245066. Epub 2009 Oct 9.

Supplemental Content

Loading ...
Support Center